ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Caryn Lerman Recruited By Univ. Of Pennsylvania.

September 28, 2001

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

December 12, 2003

National Breast Cancer Coalition Seeks Nominations For “Golden Boob Award.”

May 12, 2006

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008